What else was in the news today?

Today’s news contained items that run the spectrum from the clinical value of tomatoes and lycopene via the cardiovascular side effects of LHRH agonists and antagonists to the question of whether proton beam radiation therapy is really cost-effective. So here are the “news shorts” for the day: … READ MORE …

Lycopene, selenium, GTCs, and (maybe?) the prevention of prostate cancer — or maybe not

There have really been very few meaningful, randomized, double-blind trials of any forms of supplement in the prevention of prostate cancer … and to date none of the trials that have been done have shown unarguably meaningful, positive results. … READ MORE …

Lycopene and prostate cancer prevention in African American men

Over the years there has been much noise and little good data regarding the effects of lycopene in the prevention of prostate cancer. Indeed, all we can really say today is that there is an association between eating tomato-based products and a reduced risk for prostate cancer. … READ MORE …

Why do some nutritional supplements seem to delay prostate cancer progression?

It is widely recognized that some nutritional supplements and other dietary products seem to to have some effect on risk of prostate cancer progression. The problem is that we really don’t know why or how. … READ MORE …

Of tomatoes, lycopene, and the power of persuasion

The potential of lycopene (a natural product found at relatively high levels in tomatoes) to prevent prostate cancer is still much debated by the scientific community. By contrast, the potential of advertising to influence consumer behavior is not! So … READ MORE …

Prostate cancer news reports: Friday, June 26, 2009

Today’s prostate cancer news report summary includes items dealing with:

  • The epigenetics of prostate cancer and their potential importance
  • Selenium + vitamin E + lycopene (in mice)
  • Gleason 7: 4 + 3 versus 3 + 4 — it’s important
  • Proton beam radiotherapy — a topical review
  • EBRT + low dose, permanent seed brachytherapy … READ MORE …

The Tuesday news reports: February 24, 2009

We have dealt separately with an article on the way in which surgical technique appears to affect the likelihood of positive surgical margins after robot-assisted laparoscopic prostatectomy (RALP). Other reports today cover:

  • Whether multifocal tumors are “riskier” that single prostate cancer tumors
  • The role of n-3 fatty acids in prevention of selected cancers (including prostate cancer)
  • Lycopene in prevention and treatment of prostate cancer
  • Serum cholesterol levels and prostate cancer
  • Different forms of imaging for prostate cancer localization during EBRT
  • Carboplatin + etopside chemotherapy in late-stage metastatic disease … READ MORE …